Neoclone - We excel in the manufacture of monoclonal antibodies
Search

Can't Find It? Try Our Site Map
Product Catalog Custom Services Company Support
 

COMPANY
NeoClone News
6/07: NeoClone receives $750K federal contract for ovarian cancer detection

11/05: NeoClone featured in Wisconsin Capital Times Article on Debt Funding
9/05: NeoClone and Pierce Biotechnology agree to co-develop novel immunoaffinity products.
9/05: NeoClone presents at BIO Mid-America Venture Forum
NeoClone CEO Deven McGlenn presented at the BIO Mid-America Venture Forum in Minneapolis on September 21st-23rd, 2005.
3/05: NeoClone Presents at Proteomics Interest Group Meeting of the NCI EDRN Steering Committee
2/05: NeoClone Participates in Jetro BioMission to Chiba Prefecture
1/05: NeoClone certified as New Business Venture by State of Wisconsin Department of Commerce
11/04: NeoClone Biotechnology awarded a Phase I SBIR Contract from the National Cancer Institute to develop antibody microarrays
8/04: Abstract of article appearing in August issue of Genetic Engineering News
6/04: Read about NeoClone and Wisconsin biotechnology as featured in Milwaukee Journal Sentinel
6/04: NeoClone featured in Modern Drug Discovery article on Wisconsin biotech activity
6/04: NeoClone Licensed Protein Purification System from WARF
3/04: NeoClone Secures Wisconsin Development Funding
12/03: NeoClone Hires Dr. Michael Zwick to Fill VP of Business Development

© Copyright 2002-2003 Neoclone - All Rights Reserved.